OCS Liver PROTECT Continuation Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 24, 2016

Primary Completion Date

November 5, 2021

Study Completion Date

November 5, 2021

Conditions
Liver Transplant
Interventions
DEVICE

OCS Liver

Transplanted with a OCS preserved liver

Trial Locations (17)

21205

Johns Hopkins, Baltimore

22903

University of Virginia, Charlottesville

23298

Virginia Commonwealth University Health System, Richmond

30322

Emory, Atlanta

33606

Tampa General, Tampa

38104

University of Tennessee Health Science Center, Memphis

43210

Ohio State University Medical Center, Columbus

48202

Henry Ford Hospital, Detroit

55455

University of Minnesota, Minneapolis

75390

University of Texas Southwest, Dallas

77030

Houston Methodist Hospital, Houston

78229

The University of Texas Health Science Center at San Antonio, San Antonio

92037

University of California San Diego, La Jolla

92121

Scripps, San Diego

94143

University of California San Francisco, San Francisco

98195

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT05096741 - OCS Liver PROTECT Continuation Post-Approval Study | Biotech Hunter | Biotech Hunter